317 related articles for article (PubMed ID: 23818348)
1. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of treatment for T3N0 colon cancer.
Yo IS; Opelka FG; Bolton JS; Fuhrman GM
Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
[TBL] [Abstract][Full Text] [Related]
8. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
9. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
10. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
11. Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.
Bulent Akinci M; Algin E; Inal A; Odabas H; Berk V; Coskun U; Uyeturk U; Isikdogan A; Aksoy S; Civelek B; Sevinc A; Buyukberber S
J BUON; 2013; 18(2):314-20. PubMed ID: 23818340
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J;
Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886
[TBL] [Abstract][Full Text] [Related]
13. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
14. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer.
Nissan A; Protic M; Bilchik AJ; Howard RS; Peoples GE; Stojadinovic A
Ann Surg; 2012 Sep; 256(3):412-27. PubMed ID: 22871988
[TBL] [Abstract][Full Text] [Related]
15. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.
Artac M; Turhal NS; Kocer M; Karabulut B; Bozcuk H; Yalcin S; Karaagac M; Gündüz S; Isik N; Uygun K
Tumori; 2014; 100(2):143-8. PubMed ID: 24852857
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
17. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
[TBL] [Abstract][Full Text] [Related]
18. High-risk stage II colon cancer after curative resection.
Sato H; Maeda K; Sugihara K; Mochizuki H; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hirai T; Ohue M; Shirouzu K; Sakai Y; Watanabe T; Hirata K; Hatakeyama K
J Surg Oncol; 2011 Jul; 104(1):45-52. PubMed ID: 21416472
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group Study.
Kucukzeybek Y; Dirican A; Demir L; Yildirim S; Akyol M; Yildiz Y; Bayoglu IV; Alacacioglu A; Varol U; Salman T; Yildiz I; Can H; Tarhan MO
Asian Pac J Cancer Prev; 2015; 16(6):2413-8. PubMed ID: 25824774
[TBL] [Abstract][Full Text] [Related]
20. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer.
Demir L; Somali I; Oktay Tarhan M; Erten C; Ellidokuz H; Can A; Dirican A; Vedat Bayoglu I
J BUON; 2011; 16(4):682-8. PubMed ID: 22331722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
